Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity

Vincent L. Reynolds, Ian J. Molineux, Laurence Hurley, David H. Swenson, Laurence H. Hurley

Research output: Contribution to journalArticle

236 Citations (Scopus)

Abstract

CC-1065 is a unique antitumor antibiotic produced by Streptomyces zelensis. The potent cytotoxic effects of this drug are thought to be due to its ability to form a covalent adduct with DNA through N3 of adenine. Thermal treatment of CC-1065-DNA adducts leads to DNA strand breakage. We have shown that the CC-1065 structural modification of DNA that leads to DNA strand breakage is related to the primary alkylation site on DNA. The thermally induced DNA strand breakage occurs between the deoxyribose at the adenine covalent binding site and the phosphate on the 3′ side. No residual modification of DNA is detected on the opposite strand around the CC-1065 lesion. Using the early promoter element of SV40 DNA as a target, we have examined the DNA sequence specificity of CC-1065. A consensus sequence analysis of CC-1065 binding sites on DNA reveals two distinct classes of sequences for which CC-1065 is highly specific, i.e., 5′PuNTTA and 5′AAAAA. The orientation of the DNA sequence specificity relative to the covalent binding site provides a basis for predicting the polarity of drug binding in the minor groove. Stereo drawings of the CC-1065-DNA adduct are proposed that are predictive of features of the CC-1065-DNA adduct elucidated in this investigation.

Original languageEnglish (US)
Pages (from-to)6228-6237
Number of pages10
JournalBiochemistry
Volume24
Issue number22
StatePublished - 1985
Externally publishedYes

Fingerprint

CC 1065
DNA sequences
DNA Sequence Analysis
Anti-Bacterial Agents
DNA
Binding Sites
Adenine
Deoxyribose
DNA Adducts
Consensus Sequence
Alkylation
Streptomyces
Pharmaceutical Preparations
Sequence Analysis

ASJC Scopus subject areas

  • Biochemistry

Cite this

Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity. / Reynolds, Vincent L.; Molineux, Ian J.; Hurley, Laurence; Swenson, David H.; Hurley, Laurence H.

In: Biochemistry, Vol. 24, No. 22, 1985, p. 6228-6237.

Research output: Contribution to journalArticle

Reynolds, Vincent L. ; Molineux, Ian J. ; Hurley, Laurence ; Swenson, David H. ; Hurley, Laurence H. / Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity. In: Biochemistry. 1985 ; Vol. 24, No. 22. pp. 6228-6237.
@article{347ea65e95224da9b0f4c4ef31b10d85,
title = "Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity",
abstract = "CC-1065 is a unique antitumor antibiotic produced by Streptomyces zelensis. The potent cytotoxic effects of this drug are thought to be due to its ability to form a covalent adduct with DNA through N3 of adenine. Thermal treatment of CC-1065-DNA adducts leads to DNA strand breakage. We have shown that the CC-1065 structural modification of DNA that leads to DNA strand breakage is related to the primary alkylation site on DNA. The thermally induced DNA strand breakage occurs between the deoxyribose at the adenine covalent binding site and the phosphate on the 3′ side. No residual modification of DNA is detected on the opposite strand around the CC-1065 lesion. Using the early promoter element of SV40 DNA as a target, we have examined the DNA sequence specificity of CC-1065. A consensus sequence analysis of CC-1065 binding sites on DNA reveals two distinct classes of sequences for which CC-1065 is highly specific, i.e., 5′PuNTTA and 5′AAAAA. The orientation of the DNA sequence specificity relative to the covalent binding site provides a basis for predicting the polarity of drug binding in the minor groove. Stereo drawings of the CC-1065-DNA adduct are proposed that are predictive of features of the CC-1065-DNA adduct elucidated in this investigation.",
author = "Reynolds, {Vincent L.} and Molineux, {Ian J.} and Laurence Hurley and Swenson, {David H.} and Hurley, {Laurence H.}",
year = "1985",
language = "English (US)",
volume = "24",
pages = "6228--6237",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "22",

}

TY - JOUR

T1 - Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity

AU - Reynolds, Vincent L.

AU - Molineux, Ian J.

AU - Hurley, Laurence

AU - Swenson, David H.

AU - Hurley, Laurence H.

PY - 1985

Y1 - 1985

N2 - CC-1065 is a unique antitumor antibiotic produced by Streptomyces zelensis. The potent cytotoxic effects of this drug are thought to be due to its ability to form a covalent adduct with DNA through N3 of adenine. Thermal treatment of CC-1065-DNA adducts leads to DNA strand breakage. We have shown that the CC-1065 structural modification of DNA that leads to DNA strand breakage is related to the primary alkylation site on DNA. The thermally induced DNA strand breakage occurs between the deoxyribose at the adenine covalent binding site and the phosphate on the 3′ side. No residual modification of DNA is detected on the opposite strand around the CC-1065 lesion. Using the early promoter element of SV40 DNA as a target, we have examined the DNA sequence specificity of CC-1065. A consensus sequence analysis of CC-1065 binding sites on DNA reveals two distinct classes of sequences for which CC-1065 is highly specific, i.e., 5′PuNTTA and 5′AAAAA. The orientation of the DNA sequence specificity relative to the covalent binding site provides a basis for predicting the polarity of drug binding in the minor groove. Stereo drawings of the CC-1065-DNA adduct are proposed that are predictive of features of the CC-1065-DNA adduct elucidated in this investigation.

AB - CC-1065 is a unique antitumor antibiotic produced by Streptomyces zelensis. The potent cytotoxic effects of this drug are thought to be due to its ability to form a covalent adduct with DNA through N3 of adenine. Thermal treatment of CC-1065-DNA adducts leads to DNA strand breakage. We have shown that the CC-1065 structural modification of DNA that leads to DNA strand breakage is related to the primary alkylation site on DNA. The thermally induced DNA strand breakage occurs between the deoxyribose at the adenine covalent binding site and the phosphate on the 3′ side. No residual modification of DNA is detected on the opposite strand around the CC-1065 lesion. Using the early promoter element of SV40 DNA as a target, we have examined the DNA sequence specificity of CC-1065. A consensus sequence analysis of CC-1065 binding sites on DNA reveals two distinct classes of sequences for which CC-1065 is highly specific, i.e., 5′PuNTTA and 5′AAAAA. The orientation of the DNA sequence specificity relative to the covalent binding site provides a basis for predicting the polarity of drug binding in the minor groove. Stereo drawings of the CC-1065-DNA adduct are proposed that are predictive of features of the CC-1065-DNA adduct elucidated in this investigation.

UR - http://www.scopus.com/inward/record.url?scp=0022358966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022358966&partnerID=8YFLogxK

M3 - Article

C2 - 3002434

AN - SCOPUS:0022358966

VL - 24

SP - 6228

EP - 6237

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 22

ER -